Mesoporous silica nanoparticles as a prospective and promising approach for drug delivery and biomedical applications

X Pu, J Li, P Qiao, M Li, H Wang, L Zong… - Current cancer drug …, 2019 - ingentaconnect.com
Background: With the development of nanotechnology, nanocarrier has widely been applied
in such fields as drug delivery, diagnostic and medical imaging and engineering in recent …

Exploring the role of mesoporous silica nanoparticle in the development of novel drug delivery systems

S Stephen, B Gorain, H Choudhury… - Drug delivery and …, 2022 - Springer
The biocompatible nature of mesoporous silica nanoparticles (MSN) attracted researchers'
attention to deliver therapeutic agents in the treatment of various diseases, where their …

Recent advances in mesoporous silica nanoparticles for antitumor therapy: our contribution

A Baeza, M Manzano, M Colilla, M Vallet-Regí - Biomaterials science, 2016 - pubs.rsc.org
Since 2001, when our research group proposed for the first time MCM-41 as a drug release
system, the scientific community has demonstrated a growing interest in mesoporous silica …

[HTML][HTML] Mesoporous silica nanotechnology: promising advances in augmenting cancer theranostics

Y Dutta Gupta, Y Mackeyev, S Krishnan… - Cancer …, 2024 - Springer
Owing to unique facets, such as large surface area, tunable synthesis parameters, and ease
of functionalization, mesoporous silica nanoparticles (MSNs) have transpired as a …

Biomedical applications of mesoporous silica nanoparticles as a drug delivery carrier

H Ahmed, SS Gomte, E Prathyusha… - Journal of Drug Delivery …, 2022 - Elsevier
Mesoporous silica nanoparticles (MSNs) attracted biomedical researchers due to their
unique properties like large surface area, pore-volume, and surface-active groups. These …

Advances in regulating physicochemical properties of mesoporous silica nanocarriers to overcome biological barriers

Y Wang, K Gou, X Guo, J Ke, S Li, H Li - Acta Biomaterialia, 2021 - Elsevier
Mesoporous silica nanoparticles (MSNs) with remarkable structural features have been
proven to be an excellent platform for the delivery of therapeutic molecules. Biological …

Mesoporous silica nanoparticle: Heralding a brighter future in cancer nanomedicine

M Abbasi, SH Ghoran, MH Niakan, K Jamali… - Microporous and …, 2021 - Elsevier
Throughout the decades, selective delivery of smart diagnostic agents as well as antitumor
medications to tumor sites for early-stage cancer monitoring and avoiding hazardous effects …

[HTML][HTML] Mesoporous silica-based nanoplatforms are theranostic agents for the treatment of inflammatory disorders

BS Sivamaruthi, S Thangaleela, P Kesika, N Suganthy… - Pharmaceutics, 2023 - mdpi.com
Complete recovery from infection, sepsis, injury, or trauma requires a vigorous response
called inflammation. Inflammatory responses are essential in balancing tissue homeostasis …

[HTML][HTML] Mesoporous silica nanoparticles for drug and gene delivery

Y Zhou, G Quan, Q Wu, X Zhang, B Niu, B Wu… - … pharmaceutica sinica B, 2018 - Elsevier
Mesoporous silica nanoparticles (MSNs) are attracting increasing interest for potential
biomedical applications. With tailored mesoporous structure, huge surface area and pore …

New insights towards mesoporous silica nanoparticles as a technological platform for chemotherapeutic drugs delivery

RM Sabio, AB Meneguin, TC Ribeiro, RR Silva… - International Journal of …, 2019 - Elsevier
Mesoporous silica nanoparticles (MSNs) displays interesting properties for biomedical
applications such as high chemical stability, large surface area and tunable pores diameters …